dalteparin has been researched along with 48,XXYY Syndrome in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous reports have associated Klinefelter's syndrome with increased risk of thrombosis." | 1.39 | Klinefelter's syndrome and venous thrombosis. ( Penn, RL; Rajpal, S; Seth, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seth, A | 1 |
| Rajpal, S | 1 |
| Penn, RL | 1 |
1 other study available for dalteparin and 48,XXYY Syndrome
| Article | Year |
|---|---|
Klinefelter's syndrome and venous thrombosis.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Enoxaparin; Factor VIII; Gene Expression Regulat | 2013 |